Finance

Results: 421-432 of 21022

PR Newswire associated0

Future Minerals Forum to Announce Major Agreements Worth Billions

PR Newswire associated0

Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution

PR Newswire associated0

Rule 10b-5 Private Securities-Fraud Litigation Peaked in 4Q'24

Sobi's full year 2024 revenue higher than previous estimate

AML Incubator Launches Compliance Solution for European MSBs and VASPs Facing MiCA Regulatory Challenges

PR Newswire associated0

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Perma-Pipe International Holdings, Inc. Announces $43 Million Contract Award in the Middle East Region

Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis

Plan to tackle greedy ticket touts and give power back to fans

TrailRunner International Announces New Leadership Appointments

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global pharmaceutical companies, Dr. Leighton brings a wealth of experience in manufacturing, supply chain operations and commercial strategy. (Photo: Business Wire)

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration